News N4 Pharma Plc

Equities

Market Closed - London S.E. Other stock markets 11:35:01 2024-04-19 am EDT			5-day change	1st Jan Change
0.85 ^GBX	0.00%		+17.24%	0.00%

Apr. 18	N4 Pharma sees potential in Nuvec delivery method for cancer treatment	AN
Apr. 18	N4 Pharma’s In Vivo Testing Shows Nuvec’s Potential as Oral Delivery System	MT

N4 Pharma sees potential in Nuvec delivery method for cancer treatment	Apr. 18	AN
N4 Pharma’s In Vivo Testing Shows Nuvec’s Potential as Oral Delivery System	Apr. 18	MT
Police Arrest Two Over Attempt to Kill Murder Case	Apr. 16	AQ
N4 Pharma's In-vitro Study Shows Nuvec's Versatility in Inhibiting Cancer Cells	Feb. 15	MT
N4 Pharma shares rise on "encouraging" Nuvec research	Feb. 15	AN
AIM WINNERS & LOSERS: DSW warns on earnings amid tepid M&A markets	Feb. 15	AN
N4 Pharma plc Provides In-Vitro siRNA Update	Feb. 15	CI
N4 Pharma's Nuvec Granted Patent in India	Jan. 19	MT
N4 Pharma gets India patent for medical delivery system	Jan. 19	AN
N4 Pharma touts contract to test glaucoma treatment, ECP105	Jan. 16	AN
N4 Pharma Unit to Prepare Glaucoma Treatment Candidate for Pre-clinical Trials; Shares Plunge	Jan. 16	MT
N4 Pharma Shows Increased Transduction Efficacy for Silica Nanoparticle	Jan. 08	MT
N4 Pharma hails increased efficacy of Nuvec when complexed with AAV8	Jan. 08	AN
N4 Pharma plc Provides A Further Successful Update on Its Ongoing Research Work into the Use of Nuvec to Enhance the Performance of Viral Vector	Jan. 08	CI
FTSE 100 outperforms European peers	Dec. 18	AN
N4 Pharma rises on successful results from Nuvec administration	Dec. 18	AN
N4 Pharma Plc Provides Positive Update on its Ongoing Oral Delivery Research Work	Dec. 18	CI
N4 Pharma hails "encouraging" siRNA research	Dec. 07	AN
N4 launches investor hub; Capricorn production falls	Dec. 01	AN
Transcript : N4 Pharma Plc, Nanogenics Ltd. - M&A Call	23-10-16

No results for this search